For Assistant Professor Kaitlyn Sapoznik, OD, PhD, the eye offers more than a window into vision. It provides a remarkable view into the body's overall health, revealing changes that may occur long before a patient experiences symptoms. 

At UH Optometry, Dr. Sapoznik uses adaptive optics retinal imaging to examine the retina, revealing individual cells and tiny blood vessels in extraordinary detail, including microscopic changes that conventional clinical examinations cannot detect. First developed to improve the clarity of astronomical images, it was introduced to retinal imaging in the 1990s, opening new possibilities for studying eye diseases and detecting subtle changes in retinal health. 

"We use this technology to identify early biomarkers of vascular health in diabetes and other systemic conditions," Dr. Sapoznik said. "Our current focus is investigating the impact of antidiabetic therapies, specifically GLP-1 receptor agonists (GLP-1 RAs), on retinal vessels at the cellular level." 

Her work has led to significant findings, including microscopic changes in the walls of retinal blood vessels among people with type 2 diabetes.  

“Interestingly, as GLP-1 receptor agonists grew in popularity, a retrospective look at our data revealed that a research participant who showed no vascular remodeling had been taking a GLP-1 RA for years," she said. 

GLP-1 receptor agonists are medications commonly used to manage type 2 diabetes. The observation raised an important question: Could these medications also protect the eye's smallest blood vessels from diabetes-related changes? 

"This sparked our current investigation into whether early initiation of GLP-1 therapy might exert a protective effect on the retinal microvasculature, and our preliminary data is trending in this direction," Dr. Sapoznik said. 

Her research also investigates whether microscopic vascular changes may occur even in people with prediabetes. She is exploring these findings in collaboration with Associate Professor Wendy Harrison, OD, PhD, FAAO, whose research focuses on diabetic eye disease. 

“This work has strong potential to advance early detection, helping us identify individuals at higher risk for diabetic microvascular complications before clinical damage occurs,” Dr. Sapoznik said. “Because the retina serves as a direct window into systemic microvascular health, high-resolution imaging also offers a unique, non-invasive way to monitor how individual patients respond to specific systemic medications over time.”

In 2025, Dr. Sapoznik received a K12 award through the Consortium for Translational and Precision Health K12 Scholars Program, a partnership between the University of Houston and Baylor College of Medicine that supports early-career faculty working to translate scientific discoveries into everyday clinical practice. 

Receiving the K12 award has been instrumental, Dr. Sapoznik said, as a key challenge is the time required to analyze the detailed images produced by adaptive optics technology. With access to researchers and mentors at both institutions, Dr. Sapoznik is exploring more efficient approaches to image analysis that could make the technology more practical for routine clinical use. 

Her research could help clinicians detect disease earlier, monitor patients' responses to treatment, and make more personalized care decisions.  

Finding Her Path in Vision Science  
 
That connection between the eye and overall health first drew Dr. Sapoznik to optometry.  

As an undergraduate working at a multidisciplinary medical center on Chicago's West Side, she discovered the broad range of conditions optometrists manage. One memorable encounter involved a patient experiencing a hypertensive crisis, showing how an eye examination could reveal serious health concerns beyond vision problems. 

"I was particularly fascinated by how much an eye exam can reveal a patient's systemic health," she said. 

After graduating from the Illinois College of Optometry, Dr. Sapoznik completed an ocular disease residency and earned a PhD in Vision Science from the Indiana University School of Optometry. There, she worked with experts in retinal imaging technology and discovered how scientific findings could translate into advances in patient care. 

UH Optometry’s reputation as a leader in optometric education and vision science later drew Dr. Sapoznik to the college, where she now teaches ocular pathology courses, in ocular disease clinic, and collaborates with faculty on projects that fuel her natural curiosity.  

Shaping the Future of Optometry  

Alongside her research, Dr. Sapoznik finds fulfillment in mentoring future optometrists. Recognizing that everyone learns differently, she especially enjoys helping students grasp challenging concepts and experience those "aha moments" when everything clicks. 

"I hope students see that optometry offers diverse pathways to make a meaningful difference," she said. "Whether in primary care, specialized clinics, or research, there are countless ways to contribute to patient outcomes and advance the profession." 

Her own work expands that potential, with research that helps position optometry to play a greater role in understanding and managing conditions that affect the entire body. 

"I am continually amazed by how much we can learn about systemic health through the retina as imaging technologies advance," she said. "These insights will directly inform future optometric practice, empowering us to detect, monitor, and co-manage systemic diseases more effectively alongside a broader healthcare team."